As of 2025-05-31, the Intrinsic Value of Abivax SA (ABVX.PA) is -13.89 EUR. This ABVX.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.28 EUR, the upside of Abivax SA is -363.08%.
Based on its market price of 5.28 EUR and our intrinsic valuation, Abivax SA (ABVX.PA) is overvalued by 363.08%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13.89 - -13.89 | -13.89 | -363.08% |
| P/E | (14.89) - (15.11) | (14.17) | -368.3% |
| DDM - Stable | (19.36) - (81.91) | (50.63) | -1059.0% |
| DDM - Multi | (15.09) - (53.47) | (23.99) | -554.3% |
| Market Cap (mil) | 334.96 |
| Beta | 1.70 |
| Outstanding shares (mil) | 63.44 |
| Enterprise Value (mil) | 286.94 |
| Market risk premium | 5.82% |
| Cost of Equity | 10.55% |
| Cost of Debt | 5.00% |
| WACC | 9.26% |